comparemela.com

Latest Breaking News On - Kazumi kobayashi - Page 1 : comparemela.com

CoVIg-19 Plasma Alliance veröffentlicht Topline-Ergebnisse der von den NIH mitfinanzierten klinischen Studie mit dem COVID-19-Hyperimmunglobulin-Prüfmedikament

CoVIg-19 Plasma Alliance veröffentlicht Topline-Ergebnisse der von den NIH mitfinanzierten klinischen Studie mit dem COVID-19-Hyperimmunglobulin-Prüfmedikament
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
businesswireindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswireindia.com Daily Mail and Mail on Sunday newspapers.

Takeda and IDT Support Manufacturing of Johnson & Johnson s COVID-19 Vaccine

Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine Monday, March 15, 2021 5:35PM IST (12:05PM GMT) − Takeda will make manufacturing capacity available at IDT’s facilities in Germany   Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. At the end of a three-month period, the capacity will be returned to Takeda to resume critical manufacturing for the planned launch of its dengue vaccine, subject to regulatory approvals.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.